The International Council for Harmonisation (ICH) entitled “ICH E22 General considerations for patient preference studies” has released a draft scientific guideline open for public consultation on the EMA website until12 April 2026. The aim of this harmonised...
Genomic technologies are rapidly advancing and have accelerated discoveries across a range of conditions including cancer, rare diseases, infectious diseases and complex noncommunicable disorders. These technologies have improved clinical practice and biomedical...
The use of Artificial Intelligence technologies across medicines lifecycle has significantly increased in recent years and holds great promise as a tool to accelerate the path from innovation to safe and efficacious medicines. In this context, the European Medicine...
World leaders meeting on 16 December 2025 at the 8th United Nations General Assembly (UNGA) have adopted a historic political declaration to accelerate global action on noncommunicable diseases (NCDs) and mental health, marking a major step forward for health equity...
The Declaration on the European Innovation and Care Ecosystem for Rare and Complex Diseases has been released following the High-Level Meeting on a European research and innovation ecosystem for rare diseases. This meeting took place on 9-11 December 2025 in Brussels...
The World Health Organization (WHO) has released a new technical report outlining global research priorities for paediatric clinical trials. The publication, The future of paediatric clinical trials – setting research priorities for child health, establishes a...
The University of Pavia has released the call for applications for the two-year Second-Level University Master in Regulatory Sciences “G. Benzi”, established for the 2025–2027 academic cycle and hosted by the Department of Biology and Biotechnology “Lazzaro...
National Competent Authorities and Ethics Committees across the EU/EEA have agreed to test a new coordinated fast-track process for the assessment of multi-national clinical trials. The initiative, called FAST-EU (Facilitating and Accelerating Strategic Trials), aims...
On 10 October the European Medicine Agency has published the “ICH M14 Guideline on general principles on planning, designing, analysing, and reporting of non-interventional studies that utilise Real-World Data for safety assessment of medicines” which will come into...
Currently, antibiotic resistance has become a serious problem worldwide contributing to morbidity and mortality and increasing the burden for society and hospitalisation costs. This is the reason why there is an increasing interest in the use of phages for the...
Recent posts in News, OrphaDev4Kids